In Vitro Chemoresistance and Chemosensitivity Assays
This policy governs BCBSNM reimbursement for in vitro chemosensitivity and chemoresistance laboratory assays and applies to providers submitting claims to Blue Cross Blue Shield of New Mexico; plan documents and provider contracts may supersede this policy.
Document updated with literature review; reimbursement information unchanged.
Coverage Criteria: Reimbursement Stance
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.